These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 29264441)

  • 21. A MicroRNA Signature for Evaluation of Risk and Severity of Autoimmune Thyroid Diseases.
    Martínez-Hernández R; Sampedro-Núñez M; Serrano-Somavilla A; Ramos-Leví AM; de la Fuente H; Triviño JC; Sanz-García A; Sánchez-Madrid F; Marazuela M
    J Clin Endocrinol Metab; 2018 Mar; 103(3):1139-1150. PubMed ID: 29325052
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of key miRNAs in papillary thyroid carcinoma based on data mining and bioinformatics methods.
    Wang J; Wu L; Jin Y; Li S; Liu X
    Biomed Rep; 2020 Jan; 12(1):11-16. PubMed ID: 31839944
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of BRAF V600E Mutation and MicroRNA Expression with Central Lymph Node Metastases in Papillary Thyroid Cancer: A Prospective Study from Four Endocrine Surgery Centers.
    Han PA; Kim HS; Cho S; Fazeli R; Najafian A; Khawaja H; McAlexander M; Dy B; Sorensen M; Aronova A; Sebo TJ; Giordano TJ; Fahey TJ; Thompson GB; Gauger PG; Somervell H; Bishop JA; Eshleman JR; Schneider EB; Witwer KW; Umbricht CB; Zeiger MA
    Thyroid; 2016 Apr; 26(4):532-42. PubMed ID: 26950846
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum microRNA profiling to distinguish papillary thyroid cancer from benign thyroid masses.
    Graham ME; Hart RD; Douglas S; Makki FM; Pinto D; Butler AL; Bullock M; Rigby MH; Trites JR; Taylor SM; Singh R
    J Otolaryngol Head Neck Surg; 2015 Sep; 44(1):33. PubMed ID: 26341226
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Associations of miR-146a and miR-146b expression and clinical characteristics in papillary thyroid carcinoma.
    Sun M; Fang S; Li W; Li C; Wang L; Wang F; Wang Y
    Cancer Biomark; 2015; 15(1):33-40. PubMed ID: 25524940
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression Levels of miR-30a-5p in Papillary Thyroid Carcinoma: A Comparison Between Serum and Fine Needle Aspiration Biopsy Samples.
    Igci YZ; Ozkaya M; Korkmaz H; Bozgeyik E; Bayraktar R; Ulasli M; Erkilic S; Eraydin A; Oztuzcu S
    Genet Test Mol Biomarkers; 2015 Aug; 19(8):418-23. PubMed ID: 26047355
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In-depth characterization of the microRNA transcriptome in normal thyroid and papillary thyroid carcinoma.
    Swierniak M; Wojcicka A; Czetwertynska M; Stachlewska E; Maciag M; Wiechno W; Gornicka B; Bogdanska M; Koperski L; de la Chapelle A; Jazdzewski K
    J Clin Endocrinol Metab; 2013 Aug; 98(8):E1401-9. PubMed ID: 23783103
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential expression levels of plasma-derived miR-146b and miR-155 in papillary thyroid cancer.
    Lee YS; Lim YS; Lee JC; Wang SG; Park HY; Kim SY; Lee BJ
    Oral Oncol; 2015 Jan; 51(1):77-83. PubMed ID: 25456009
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum miR-22 may be a biomarker for papillary thyroid cancer.
    Wang D; Guo C; Kong T; Mi G; Li J; Sun Y
    Oncol Lett; 2019 Mar; 17(3):3355-3361. PubMed ID: 30867770
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mapping the Molecular Basis and Markers of Papillary Thyroid Carcinoma Progression and Metastasis Using Global Transcriptome and microRNA Profiling.
    Akyay OZ; Gov E; Kenar H; Arga KY; Selek A; Tarkun İ; Canturk Z; Cetinarslan B; Gurbuz Y; Sahin B
    OMICS; 2020 Mar; 24(3):148-159. PubMed ID: 32073999
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Altered expression of DLG1-AS1 distinguished papillary thyroid carcinoma from benign thyroid nodules.
    He T; Wang H; Sun J; Wu J; Gong F; Li S; Wang H; Li Y
    BMC Endocr Disord; 2019 Nov; 19(1):122. PubMed ID: 31718630
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MiR-146b-5p Regulates the Expression of Long Noncoding RNA
    Peng Y; Fang X; Yao H; Zhang Y; Shi J
    Cancer Biother Radiopharm; 2021 Jun; 36(5):433-440. PubMed ID: 32343601
    [No Abstract]   [Full Text] [Related]  

  • 33. Specific Autoantibodies and Clinical Phenotypes Correlate with the Aberrant Expression of Immune-Related MicroRNAs in Dermatomyositis.
    Ye L; Zuo Y; Yang H; Li W; Peng Q; Lu X; Wang G; Shu X
    J Immunol Res; 2019; 2019():2927061. PubMed ID: 30915368
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In Situ Hybridization Analysis of miR-146b-5p and miR-21 in Thyroid Nodules: Diagnostic Implications.
    Guo Z; Hardin H; Montemayor-Garcia C; Asioli S; Righi A; Maletta F; Sapino A; Lloyd RV
    Endocr Pathol; 2015 May; 26(2):157-63. PubMed ID: 25771986
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aberrant expression of microRNA-132-3p and microRNA-146a-5p in Parkinson's disease patients.
    Shu Y; Qian J; Wang C
    Open Life Sci; 2020; 15(1):647-653. PubMed ID: 33817253
    [TBL] [Abstract][Full Text] [Related]  

  • 36. miR-1301-3p suppresses tumor growth by downregulating PCNA in thyroid papillary cancer.
    Qiao DH; He XM; Yang H; Zhou Y; Deng X; Cheng L; Zhou XY
    Am J Otolaryngol; 2021; 42(2):102920. PubMed ID: 33454555
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dysregulated Serum MiRNA Profile and Promising Biomarkers in Dengue-infected Patients.
    Ouyang X; Jiang X; Gu D; Zhang Y; Kong SK; Jiang C; Xie W
    Int J Med Sci; 2016; 13(3):195-205. PubMed ID: 26941580
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Microarray profiling of circular RNAs in human papillary thyroid carcinoma.
    Peng N; Shi L; Zhang Q; Hu Y; Wang N; Ye H
    PLoS One; 2017; 12(3):e0170287. PubMed ID: 28288173
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MicroRNA-146b-5p as an oncomiR promotes papillary thyroid carcinoma development by targeting CCDC6.
    Jia M; Shi Y; Li Z; Lu X; Wang J
    Cancer Lett; 2019 Feb; 443():145-156. PubMed ID: 30503553
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of Circulating miRNAs Differentially Regulated by Opioid Treatment.
    Toyama K; Kiyosawa N; Watanabe K; Ishizuka H
    Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28926935
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.